ED90 of 0.08% ropivacaine combined with 0.4 µg/mL dexmedetomidine in PIEB intermittent pulse

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059558

Enrollment

Unknown

Registered

2022-05-04

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 30:Ropivacaine

Group 35:Ropivacaine

Group 40:Ropivacaine

Group 45:Ropivacaine

Group 50:Ropivacaine

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA statue of I or II, patients with a single pregnancy, at full-term (gestational aged >= 37 weeks).

Exclusion criteria

Exclusion criteria: 1. Obesity (BMI>35kg/m^2); 2. Active labor preterm diabetes or gestational diabetes, hypertension or preeclampsia; 3. Intrauterine growth restriction or giant fetus, placenta previa, placenta adhesion, placenta accreta, major maternal diseases; 4. Absolute contraindications to spinal or epidural anesthesia, such as local infection or bleeding disorders.

Design outcomes

Primary

Measure	Time frame
effective analgesia rate;	—

Secondary

Measure	Time frame
anesthesia block plane;motor block rate;incidence of hypotension;	—

Countries

China

Contacts

Public ContactXiao Fei

1370697501@136.com+86 13706597501

Outcome results